US 11,752,146 B2
Anti-inflammatory, anti-cancer, and anti-angiogenic compounds, pharmaceutical compositions, and methods of making and using thereof
Basil Rigas, Setauket, NY (US)
Assigned to MEDICON PHARMACEUTICALS, INC., Setauket, NY (US)
Appl. No. 16/651,826
Filed by MEDICON PHARMACEUTICALS, INC., Setauket, NY (US)
PCT Filed Sep. 28, 2018, PCT No. PCT/US2018/053537
§ 371(c)(1), (2) Date Mar. 27, 2020,
PCT Pub. No. WO2019/067974, PCT Pub. Date Apr. 4, 2019.
Claims priority of provisional application 62/564,610, filed on Sep. 28, 2017.
Prior Publication US 2020/0246330 A1, Aug. 6, 2020
Int. Cl. A61K 31/495 (2006.01); A61P 27/02 (2006.01); A61P 35/00 (2006.01); A61K 9/00 (2006.01); A61K 31/166 (2006.01); A61K 31/664 (2006.01); A61K 45/06 (2006.01); C07C 233/78 (2006.01); C07D 241/04 (2006.01); C07F 9/22 (2006.01)
CPC A61K 31/495 (2013.01) [A61K 9/0019 (2013.01); A61K 9/0048 (2013.01); A61K 31/166 (2013.01); A61K 31/664 (2013.01); A61K 45/06 (2013.01); A61P 27/02 (2018.01); A61P 35/00 (2018.01); C07C 233/78 (2013.01); C07D 241/04 (2013.01); C07F 9/222 (2013.01)] 8 Claims
OG exemplary drawing
 
1. A compound or a pharmaceutically acceptable salt, solvate, hydrate, cocrystal, or prodrug thereof, selected from Compound 1, Compound 2, Compound 3, and Compound 4:

OG Complex Work Unit Chemistry